Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,122,000 | 3,406,000 | 1,827,000 | 2,247,000 | 1,808,000 |
| Marketable Securities | 21,609,000 | 22,069,000 | 25,886,000 | 19,979,000 | 18,085,000 |
| Receivables | 8,958,000 | 9,843,000 | 9,392,000 | 9,103,000 | 9,367,000 |
| Inventories | 4,381,000 | 5,302,000 | 6,111,000 | 5,478,000 | 6,660,000 |
| Other current assets | 972,000 | 731,000 | 576,000 | 7,169,000 | 835,000 |
| TOTAL | $43,076,000 | $46,849,000 | $47,658,000 | $46,835,000 | $39,088,000 |
| Non-Current Assets | |||||
| PPE Net | 13,287,000 | 15,734,000 | 16,632,000 | 16,233,000 | 18,385,000 |
| Investments And Advances | 11,478,000 | 4,856,000 | 3,892,000 | 2,497,000 | 3,873,000 |
| Intangibles | 39,185,000 | 41,880,000 | 45,226,000 | 47,229,000 | 57,007,000 |
| Other Non-Current Assets | 4,122,000 | 5,949,000 | 2,138,000 | 4,176,000 | 4,725,000 |
| TOTAL | $68,072,000 | $68,419,000 | $67,888,000 | $70,135,000 | $83,990,000 |
| Total Assets | $111,148,000 | $115,268,000 | $115,546,000 | $116,970,000 | $123,078,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,320,000 | 5,825,000 | 2,434,000 | 11,589,000 | 11,266,000 |
| Accounts payable and accrued liabilities | 1,751,000 | 2,270,000 | 2,019,000 | 2,073,000 | 2,672,000 |
| Accrued Expenses | 1,667,000 | 1,974,000 | 1,903,000 | 1,602,000 | 1,939,000 |
| Other current liabilities | 11,456,000 | 8,223,000 | 6,512,000 | 6,521,000 | 7,200,000 |
| TOTAL | $27,009,000 | $21,835,000 | $22,099,000 | $28,402,000 | $26,458,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,963,000 | 7,314,000 | 5,546,000 | 6,347,000 | 7,279,000 |
| aiOther Non-Current Liabilities | 15,454,000 | 13,371,000 | 8,528,000 | 6,750,000 | 9,037,000 |
| TOTAL | $26,399,000 | $28,423,000 | $22,089,000 | $22,804,000 | $28,342,000 |
| Total Liabilities | $53,408,000 | $50,258,000 | $44,188,000 | $51,206,000 | $54,800,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,745,270 | 6,760,989 | 7,086,916 | 7,357,944 | 7,458,874 |
| Common Shares | 443,000 | 442,000 | 441,000 | 439,000 | 438,000 |
| Retained earnings | 49,142,000 | 49,660,000 | 49,669,000 | 37,608,000 | 35,492,000 |
| Other shareholders' equity | -4,737,000 | 1,842,000 | -1,116,000 | -275,000 | 1,242,000 |
| TOTAL | $57,740,000 | $65,010,000 | $71,358,000 | $65,764,000 | $68,278,000 |
| Total Liabilities And Equity | $111,148,000 | $115,268,000 | $115,546,000 | $116,970,000 | $123,078,000 |